FcYγRIV deletion reveals its central role for IgG2a and IgG2b activity in vivo

Proceedings of the National Academy of Sciences of the United States of America

Volumn 107, Issue 45, 2010, Pages 19396-19401

  Nimmerjahn, Falk ^a   Lux, Anja ^a   Albert, Heike ^a   Woigk, Melissa ^a   Lehmann, Christian ^b   Dudziak, Diana ^b   Smith, Patrick ^c   Ravetch, Jeffrey V ^c  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c ROCKEFELLER UNIVERSITY   (United States)

Author keywords

Autoimmune disease; Immunoglobulin G; Inflammation

Indexed keywords

CD11B ANTIGEN; CD16 ANTIGEN; FC RECEPTOR; FC RECEPTOR IV; IMMUNOGLOBULIN G2A; IMMUNOGLOBULIN G2B; UNCLASSIFIED DRUG; FCGR4 PROTEIN, MOUSE; IMMUNOGLOBULIN G;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHUS PHENOMENON; AUTOIMMUNITY; BLOOD; BONE MARROW; CELL MEDIATED CYTOTOXICITY; CONFERENCE PAPER; EFFECTOR CELL; GENE DELETION; GRANULOCYTE; IMMUNE COMPLEX NEPHRITIS; IN VIVO STUDY; INNATE IMMUNITY; KNOCKOUT MOUSE; MELANOMA; MONOCYTE; MOUSE; NONHUMAN; PASSIVE SKIN ANAPHYLAXIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN; ANIMAL; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ARTICLE; IMMUNOLOGY; MOUSE MUTANT; PHYSIOLOGY;

MUS;

ANIMALS; ANTIBODY-DEPENDENT CELL CYTOTOXICITY; AUTOIMMUNITY; IMMUNOGLOBULIN G; MICE; MICE, KNOCKOUT; MODELS, ANIMAL; RECEPTORS, IGG;

EID: 78650608742     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1014515107     Document Type: Article

References (31)

1. Hogarth PM (2002) Fc receptors are major mediators of antibody based inflammation in autoimmunity. Curr Opin Immunol 14:798-802.
2. Nimmerjahn F, Ravetch JV (2010) Antibody-mediated modulation of immune responses. Immunol Rev 236:265-275.
3. Takai T (2002) Roles of Fc receptors in autoimmunity. Nat Rev Immunol 2:580-592.
4. Nimmerjahn F, Ravetch JV (2008) Fcgamma receptors as regulators of immune responses. Nat Rev Immunol 8:34-47.
5. Ravetch JV, Clynes RA (1998) Divergent roles for Fc receptors and complement in vivo. Annu Rev Immunol 16:421-432.
6. Hessell AJ, et al. (2007) Fc receptor but not complement binding is important in antibody protection against HIV. Nature 449:101-104.
7. Cartron G, et al. (2002) Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcgammaRIIIa gene. Blood 99:754-758.
8. Weng WK, Czerwinski D, Timmerman J, Hsu FJ, Levy R (2004) Clinical outcome of lymphoma patients after idiotype vaccination is correlated with humoral immune response and immunoglobulin G Fc receptor genotype. J Clin Oncol 22:4717-4724.
9. Weng WK, Levy R (2003) Two immunoglobulin G fragment C receptor polymorphisms independently predict response to rituximab in patients with follicular lymphoma. J Clin Oncol 21:3940-3947.
10. Fossati-Jimack L, et al. (2000)Markedly different pathogenicity of four immunoglobulinG isotype-switch variants of an antierythrocyte autoantibody is based on their capacity to interact in vivo with the low-affinity Fcgamma receptor III. J ExpMed 191:1293-1302.
11. Hamaguchi Y, Xiu Y, Komura K, Nimmerjahn F, Tedder TF (2006) Antibody isotypespecific engagement of Fcgamma receptors regulates B lymphocyte depletion during CD20 immunotherapy. J Exp Med 203:743-753.
12. Hazenbos WL, et al. (1996) Impaired IgG-dependent anaphylaxis and Arthus reaction in Fc gamma RIII (CD16) deficient mice. Immunity 5:181-188.
13. Meyer D, et al. (1998) FcgammaRIII (CD16)-deficient mice show IgG isotype-dependent protection to experimental autoimmune hemolytic anemia. Blood 92:3997-4002.
14. Nimmerjahn F, Ravetch JV (2005) Divergent immunoglobulin g subclass activity through selective Fc receptor binding. Science 310:1510-1512.
15. Nimmerjahn F, Bruhns P, Horiuchi K, Ravetch JV (2005) FcgammaRIV: A novel FcR with distinct IgG subclass specificity. Immunity 23:41-51.
16. Barnes N, et al. (2002) FcgammaRI-deficient mice show multiple alterations to inflammatory and immune responses. Immunity 16:379-389.
17. Ioan-Facsinay A, et al. (2002) FcgammaRI (CD64) contributes substantially to severity of arthritis, hypersensitivity responses, and protection from bacterial infection. Immunity 16:391-402.
18. Hirano M, et al. (2007) IgEb immune complexes activate macrophages through FcgammaRIV binding. Nat Immunol 8:762-771.
19. Mancardi DA, et al. (2008) FcgammaRIV is a mouse IgE receptor that resembles macrophage FcepsilonRI in humans and promotes IgE-induced lung inflammation. J Clin Invest 118:3738-3750.
20. Syed SN, et al. (2009) Both FcgammaRIV and FcgammaRIII are essential receptors mediating type II and type III autoimmune responses via FcRgamma-LAT-dependent generation of C5a. Eur J Immunol 39:3343-3356.
21. Giorgini A, et al. (2008) Fc gamma RIII and Fc gamma RIV are indispensable for acute glomerular inflammation induced by switch variant monoclonal antibodies. J Immunol 181:8745-8752.
22. Kaneko Y, Nimmerjahn F, Madaio MP, Ravetch JV (2006) Pathology and protection in nephrotoxic nephritis is determined by selective engagement of specific Fc receptors. J Exp Med 203:789-797.
23. Takai T, Li M, Sylvestre D, Clynes R, Ravetch JV (1994) FcR gamma chain deletion results in pleiotrophic effector cell defects. Cell 76:519-529. (Pubitemid 24064172)
24. Dombrowicz D, et al. (1997) Absence of Fc epsilonRI alpha chain results in upregulation of Fc gammaRIII-dependent mast cell degranulation and anaphylaxis. Evidence of competition between Fc epsilonRI and Fc gammaRIII for limiting amounts of FcR beta and gamma chains. J Clin Invest 99:915-925.
25. Sylvestre D, et al. (1996) Immunoglobulin G-mediated inflammatory responses develop normally in complement-deficient mice. J Exp Med 184:2385-2392.
26. Sylvestre DL, Ravetch JV (1994) Fc receptors initiate the Arthus reaction: Redefining the inflammatory cascade. Science 265:1095-1098.
27. Ji H, et al. (2002) Arthritis critically dependent on innate immune system players. Immunity 16:157-168.
28. Li M, Wirthmueller U, Ravetch JV (1996) Reconstitution of human Fc gamma RIII cell type specificity in transgenic mice. J Exp Med 183:1259-1263.
29. McKenzie SE, et al. (1999) The role of the human Fc receptor Fc gamma RIIA in the immune clearance of platelets: A transgenic mouse model. J Immunol 162:4311-4318.
30. Samuelsson A, Towers TL, Ravetch JV (2001) Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor. Science 291:484-486.
31. Sylvestre DL, Ravetch JV (1996) A dominant role for mast cell Fc receptors in the Arthus reaction. Immunity 5:387-390.